Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,916 DKK | -2.87% | -3.96% | -11.11% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.11% | 18.33B | |
-3.15% | 104B | |
+0.84% | 97.42B | |
+0.79% | 22.2B | |
-17.99% | 21.23B | |
-42.83% | 16.35B | |
-16.63% | 15.06B | |
+3.83% | 13.98B | |
+30.92% | 11.66B | |
-25.91% | 8.22B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Berenberg Initiates Coverage on Genmab With Sell Rating